Tango Therapeutics Inc. logo

Tango Therapeutics Inc.

TNGX | NASDAQ
Chart Builder DCF Calculator
$22.33
+$0.58 (+2.67%)
At close: Sep 21, 2026, 4:00 PM ET
$22.55
+$0.22 (+0.99%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$3.54B
Enterprise Value
$2.65B
Beta
1.12
Average Volume
3.46M
Shares Outstanding (Diluted)
149.88M
Shares Change YoY
35.58%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US87583X1090

Price Performance

Price Change 1M
-5.1%
Price Change 3M
-21.4%
Price Change 6M
6.9%
Price Change YTD
150.1%
Price Change 1Y
199.7%
Price Change 3Y
116.4%
Price Change 5Y
64.7%
1M CAGR (ann.)
-25.0%
1Y CAGR (ann.)
185.4%
5Y CAGR (ann.)
6.9%
All-Time CAGR
13.3%

Valuation

PE Ratio
-26.27
Forward PE
N/A
PEG Ratio
-0.65
Forward PEG
-1.34
PS Ratio
67.56
Forward PS
1,042.10
PB Ratio
3.55
P/FCF Ratio
-25.20
P/Adj. FCF Ratio
-19.70
P/OCF Ratio
-23.26
EV/Sales
49.31
EV/EBIT
-21.44
EV/EBITDA
-21.70
EV/FCF
-18.39
Earnings Yield
-3.8%
FCF Yield
-4.0%
Adj. FCF Yield
-5.1%

Financial Health

Net Cash
$982M
Total Debt
$31.99M
Cash & Short-Term Investments
$1.01B
Total Assets
$1.07B
Current Ratio
50.82
Quick Ratio
50.82
Debt / Equity Ratio
0.03
Debt / EBITDA
-0.26
Debt / FCF
-0.22
OCF / Debt
-4.50
Interest Coverage
0.00
Altman Z-Score
42.94
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
98.3%
Operating Profit Margin
-253.4%
EBITDA Margin
-227.3%
Net Profit Margin
-229.9%
FCF Margin
-268.1%
Adj. FCF Margin
-343.0%
SBC / Revenue
74.9%
SBC Impact (per share)
-27.9%

Returns

Return on Assets
-11.5%
Return on Equity
-25.7%
Return on Invested Capital
-12.9%
Return on Capital Employed
-12.9%
Return on Tangible Assets
-11.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
16.9%
Revenue CAGR 5Y
19.1%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
13.1%
EPS CAGR 5Y
3.1%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-8.5%
FCF CAGR 5Y
-9.2%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
13
EPS Growth Next 3Y
-17.3%
Revenue Growth Next 3Y
77.9%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.34
EPS Growth Est (next Q)
-361.5%
Revenue Est (next Q)
$3.28M
Revenue Growth Est (next Q)
-93.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$45.91
Price Target Upside
105.6%

Cash Flow

Operating Cash Flow
$-143.9M
Free Cash Flow
$-144.27M
Adj. Free Cash Flow
$-184.56M
FCF Per Share
-$0.96
OCF Per Share
-$0.96
OCF/S Ratio
-267.4%

Income Statement

Revenue
$53.81M
Gross Profit
$52.87M
Operating Income
$-136.35M
EBITDA
$-122.29M
Net Income
$-123.72M
EPS (Diluted)
-$0.85
Revenue / Employee
$392.78K
Profit / Employee
$-903.07K
Employees
137

© 2026 bestshares.com. All rights reserved.